ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OCUL Ocular Therapeutix Inc

6.76
0.13 (1.96%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ocular Therapeutix Inc NASDAQ:OCUL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.13 1.96% 6.76 6.50 6.86 6.789 6.51 6.68 2,026,963 01:00:00

Stocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix

14/12/2023 12:07am

Dow Jones News


Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Ocular Therapeutix Charts.

By Ben Glickman

 

Adobe issued fiscal first-quarter and 2024 revenue guidance below analysts estimates. The software maker also said it could face significant costs or penalties related to a Federal Trade Commission investigation into its disclosure and subscription cancellation practices. Shares fall 5.5% to $590 after-hours.

Amtech Systems warned of weaker demand for its products because of a continued downturn in the semiconductor industry. The semiconductor manufacturing equipment maker said it was looking to cut costs, including by reducing its workforce in areas of its business, and had entered a forbearance agreement with a lender. Shares were down 40% to $3.57 after-hours.

Ocular Therapeutix announced a proposed public offering of stock, the proceeds from which it plans to use to fund the development of one of its treatment candidates. The company didn't say how many shares it would sell in the secondary offering. Shares fall 15% to $3.33 after-hours.

 

Write to Ben Glickman at ben.glickman@wsj.com

 

(END) Dow Jones Newswires

December 13, 2023 18:52 ET (23:52 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year Ocular Therapeutix Chart

1 Year Ocular Therapeutix Chart

1 Month Ocular Therapeutix Chart

1 Month Ocular Therapeutix Chart

Your Recent History

Delayed Upgrade Clock